Disclosure of Conflicts of Interest

Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.  

Nicole Good has no relevant financial relationships with ineligible companies to disclose.  

Coreetha Entzminger has no relevant financial relationships with ineligible companies to disclose.

‍Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

AI Use Disclosure

Artificial intelligence (AI) tools were used in the development of this activity’s educational content. Specifically, Gamma and Synthesia were used on August 25 - September 9, 2026 to assist with slide generation and design and voiceover creation. All AI-assisted content including slides/written materials was reviewed and verified for accuracy, balance, and freedom from commercial influence by Nicole Good and Phoebe Masallo-Caballo, Premiere Content Development Team, before being provided to learners.